Ireland-based medical technology company Medtronic has obtained CE mark for its range of cardiac resynchronisation therapy pacemakers (CRT-Ps) that enable proactive heart failure management.

To be available in Europe from March, the range includes Percepta Quad CRT-P MRI SureScan, Serena Quad CRT-P MRI SureScan and Solara Quad CRT-P MRI SureScan.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

These devices allow magnetic resonance imaging (MRI) scanning in either 1.5 or 3 Tesla (T) machines.

"The algorithm is also reported to reduce the AF risk by 46%, when compared to echo-optimised biventricular pacing."

Equipped with the EffectivCRT Diagnostic, the Percepta Quad CRT-P can determine the effectiveness of each left ventricular pace and the EffectivCRT during AF algorithm automatically adjusts pacing rates during atrial fibrillation (AF).

The Percepta also features an automated in-office test called VectorExpress 2.0 that decreases lead programing to two minutes and provides clinical information to aid physicians in deciding optimal pacing configurations for each patient.

Both Percepta Quad and Serena Quad CRT-Ps also include the AdaptivCRT algorithm, which is reported to decrease the chance of a patient's readmission due to a 30 day heart failure by 59%.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The algorithm is also reported to reduce the AF risk by 46%, when compared to echo-optimised biventricular pacing.

The Percepta and Serena additionally include Multiple Point Pacing that allows simultaneous or sequential stimulation of two sites on the left ventricle.

All the three pacemakers feature the Attain Perfoma MRI SureScan Quadripolar Leads that has short bipolar spacing to decrease phrenic nerve stimulation occurrence, steroid on all electrodes and comes in three shapes for different patient anatomies.

They also include SureScan MR-conditional labeling that facilitates full-body scans without positioning restrictions.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact